Trial Site Detail

 

Drug:
CB-839
Trial:
Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study
Conditions: Solid Tumors
Trial Status:
Active, not recruiting

 

University of Miami, Sylvester Comprehensive Cancer Center

1475 Northwest 12th Ave     
Miami , FL 33136
USA

 

Principal Investigator:
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
University of Miami, Sylvester Comprehensive Cancer Center Website:
http://uhealthsystem.com/clinical-trials/browse-clinical-trials/results?tarea=Bone%20and%20Soft%20Tissue%20Cancers&division=Cancer%20Center

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.